BWAY
Price
$12.98
Change
+$0.15 (+1.17%)
Updated
Aug 15 closing price
Capitalization
246.54M
87 days until earnings call
STIM
Price
$3.34
Change
-$0.22 (-6.18%)
Updated
Aug 15 closing price
Capitalization
220.86M
86 days until earnings call
Interact to see
Advertisement

BWAY vs STIM

Header iconBWAY vs STIM Comparison
Open Charts BWAY vs STIMBanner chart's image
BrainsWay
Price$12.98
Change+$0.15 (+1.17%)
Volume$67.87K
Capitalization246.54M
Neuronetics
Price$3.34
Change-$0.22 (-6.18%)
Volume$1.3M
Capitalization220.86M
BWAY vs STIM Comparison Chart in %
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. STIM commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Hold and STIM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (BWAY: $12.98 vs. STIM: $3.34)
Brand notoriety: BWAY and STIM are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BWAY: 125% vs. STIM: 117%
Market capitalization -- BWAY: $246.54M vs. STIM: $220.86M
BWAY [@Medical/Nursing Services] is valued at $246.54M. STIM’s [@Medical/Nursing Services] market capitalization is $220.86M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whileSTIM’s FA Score has 0 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • STIM’s FA Score: 0 green, 5 red.
According to our system of comparison, STIM is a better buy in the long-term than BWAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 5 TA indicator(s) are bullish while STIM’s TA Score has 6 bullish TA indicator(s).

  • BWAY’s TA Score: 5 bullish, 5 bearish.
  • STIM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, STIM is a better buy in the short-term than BWAY.

Price Growth

BWAY (@Medical/Nursing Services) experienced а +10.37% price change this week, while STIM (@Medical/Nursing Services) price change was -19.13% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.

Reported Earning Dates

BWAY is expected to report earnings on Nov 12, 2025.

STIM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BWAY($247M) has a higher market cap than STIM($221M). STIM YTD gains are higher at: 107.453 vs. BWAY (37.646). BWAY has higher annual earnings (EBITDA): 6.57M vs. STIM (-39.54M). BWAY has more cash in the bank: 71.6M vs. STIM (20.4M). BWAY has less debt than STIM: BWAY (5.57M) vs STIM (82.5M). STIM has higher revenues than BWAY: STIM (89.4M) vs BWAY (43.5M).
BWAYSTIMBWAY / STIM
Capitalization247M221M112%
EBITDA6.57M-39.54M-17%
Gain YTD37.646107.45335%
P/E Ratio46.36N/A-
Revenue43.5M89.4M49%
Total Cash71.6M20.4M351%
Total Debt5.57M82.5M7%
FUNDAMENTALS RATINGS
BWAY vs STIM: Fundamental Ratings
BWAY
STIM
OUTLOOK RATING
1..100
3358
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
5698
SMR RATING
1..100
7699
PRICE GROWTH RATING
1..100
4142
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STIM's Valuation (40) in the Medical Specialties industry is in the same range as BWAY (72). This means that STIM’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's Profit vs Risk Rating (56) in the Medical Specialties industry is somewhat better than the same rating for STIM (98). This means that BWAY’s stock grew somewhat faster than STIM’s over the last 12 months.

BWAY's SMR Rating (76) in the Medical Specialties industry is in the same range as STIM (99). This means that BWAY’s stock grew similarly to STIM’s over the last 12 months.

BWAY's Price Growth Rating (41) in the Medical Specialties industry is in the same range as STIM (42). This means that BWAY’s stock grew similarly to STIM’s over the last 12 months.

BWAY's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as STIM (100). This means that BWAY’s stock grew similarly to STIM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYSTIM
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYBJF1.38N/A
N/A
Security Bank Corp.
HKMPF23.60N/A
N/A
Hikma Pharmaceuticals plc.
RWCRF0.40N/A
N/A
RIWI Corp.
MBOF38.98N/A
N/A
Marine Bancorp of Florida, Inc.
AMKAF2190.05-56.95
-2.53%
A.P. Moeller-Maersk A/S

BWAY and

Correlation & Price change

A.I.dvisor tells us that BWAY and ISRG have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BWAY and ISRG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
+1.17%
ISRG - BWAY
31%
Poorly correlated
+0.67%
CLPT - BWAY
31%
Poorly correlated
-1.11%
BFLY - BWAY
31%
Poorly correlated
+1.42%
ITGR - BWAY
31%
Poorly correlated
+0.02%
STIM - BWAY
30%
Poorly correlated
-6.18%
More

STIM and

Correlation & Price change

A.I.dvisor tells us that STIM and DIZTF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and DIZTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-6.18%
DIZTF - STIM
31%
Poorly correlated
N/A
BWAY - STIM
30%
Poorly correlated
+1.17%
ALGN - STIM
27%
Poorly correlated
-0.31%
NEO - STIM
26%
Poorly correlated
+0.16%
ACRS - STIM
25%
Poorly correlated
+10.65%
More